Xeno Lifecare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 13-12-2024
- Revenue 245.11%
(FY 2020)
- Profit 2592.05%
(FY 2020)
- Ebitda -472.66%
(FY 2020)
- Net Worth 947.16%
(FY 2020)
- Total Assets 123.25%
(FY 2020)
About Xeno Lifecare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Neha Tyagi and Gaurav Tyagi serve as directors at the Company.
- CIN/LLPIN
U51900UR2018PTC008735
- Company No.
008735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Xeno Lifecare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Tyagi  | Director | 12-Nov-2019 | Current |
| Gaurav Tyagi | Director | 16-May-2018 | Current |
Financial Performance of Xeno Lifecare.
Xeno Lifecare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 245.11% increase. The company also saw a substantial improvement in profitability, with a 2592.05% increase in profit. The company's net worth Soared by an impressive increase of 947.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xeno Lifecare?
In 2020, Xeno Lifecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unoscott Pharma Private LimitedActive 5 years 3 monthsNeha Tyagi and Gaurav Tyagi are mutual person
- Tesola Green Energy And Agro Private LimitedActive 2 years 8 months
Neha Tyagi and Gaurav Tyagi are mutual person
- Hardwarilal Restaurants Private LimitedActive 2 years 5 months
Neha Tyagi and Gaurav Tyagi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Jan 2023 | ₹5.00 M | Open |
How Many Employees Work at Xeno Lifecare?
Unlock and access historical data on people associated with Xeno Lifecare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xeno Lifecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xeno Lifecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
